Cocca S V
Harvard University.
Am J Law Med. 1993;19(3):313-44.
Breast cancer remains a leading cause of death among American women, yet little is known about its etiology and prevention. Screening mammography is currently the best preventative measure available to women, but comprehensive oversight of this procedure is necessary in order to minimize and, ultimately, eliminate "errors" that compromise quality and accuracy and give too many women a false sense of security. This Note describes our nation's battle against breast cancer, emphasizes the need for uniform, mandatory quality and safety standards for screening mammography, and outlines The Mammography Quality Standards Act of 1992, which seeks to provide the framework necessary to implement such standards and restore the preventative power of this procedure. This Note analyzes the terms of the Act and concludes that the Act could provide women with the true sense of security that has eluded so many women-too many women-for so long.
乳腺癌仍然是美国女性死亡的主要原因之一，然而人们对其病因和预防知之甚少。目前，乳腺钼靶筛查是女性可采用的最佳预防措施，但为了尽量减少并最终消除那些损害质量和准确性、并让太多女性产生虚假安全感的“错误”，对这一检查程序进行全面监督是必要的。本笔记描述了我国对抗乳腺癌的斗争，强调了对乳腺钼靶筛查制定统一、强制性质量和安全标准的必要性，并概述了1992年的《乳腺钼靶质量标准法案》，该法案旨在提供实施此类标准并恢复该检查程序预防效力所需的框架。本笔记分析了该法案的条款，并得出结论认为，该法案可为女性提供长久以来许多女性一直未能获得的真正安全感。
